SCHEMBL7654725

SCHEMBL7654725

CCCCc1nc(-c2ccncc2)n[nH]1

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 14/20 0.53
GRK2 P25098 12/20 0.51
PDE10A Q9Y233 1/20 0.50
GSK3B P49841 1/20 0.50
NPC1 O15118 1/20 0.47
ALDH1A1 P00352 1/20 0.47
MAPT P10636 1/20 0.47
NFKB1 P19838 1/20 0.47
S1PR1 P21453 1/20 0.47
RAB9A P51151 1/20 0.47
NFKB2 Q00653 1/20 0.47
RELA Q04206 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
DDX3X O00571 1/20 0.46
GRK3 P35626 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1899895 0.85 NR1H2 (0.58) ROCK2GRK2PDE10ANPC1RAB9A
SCHEMBL7658956 0.83 DDX3X (0.50) ROCK2NPC1RAB9ASMN1; SMN2DDX3X
SCHEMBL26108539 0.81 ADORA2A (0.47) NPC1RAB9ADDX3X
SCHEMBL7910285 0.80 ROCK2 (0.56) ROCK2GRK2PDE10A
SCHEMBL7213157 0.79 RARB (0.55) NPC1ALDH1A1MAPTNFKB1RAB9A
Hydrochloric Acid SCHEMBL14736164 0.79 ROCK2 (0.55) ROCK2GRK2PDE10A
SCHEMBL29109555 0.77 DDX3X (0.40) GSK3BNPC1MAPTNFKB1RAB9A
SCHEMBL4789632 0.76 ROCK2 (0.56) ROCK2GRK2PDE10A
SCHEMBL7218544 0.76 DDX3X (0.53) NPC1ALDH1A1MAPTRAB9ASMN1; SMN2
SCHEMBL14289634 0.75 ROCK2 (0.64) ROCK2GRK2GRK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6358984-B1 FOR THERAPY OF HYPERTENSION AND/OR DISEASES SUCH AS HEART AND RENAL DISEASES LEAD CHEMICAL CO., LTD. (JP) 2002-03-19 US disclosed
US-6232335-B1 A BIPHENYL TRIAZOLE COMPOUND USEFUL AS A ANGIOTENSIN II CONVERTING ENZYME INHIBITORS EFFECTIVE IN THE TREATMENT OF HYPERTENSION OR HEART FAILURE LEAD CHEMICAL CO., LTD. (JP) 2001-05-15 US disclosed